We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300251:SZSEBeijing Enlight Media Co., Ltd. Class A Analysis

Data as of 2026-03-16 - not real-time

CN¥16.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Beijing Enlight Media is trading at CNY 16.67, just above the computed support of CNY 16.35 and well below its 20‑day (CNY 19.84) and 50‑day (CNY 18.59) moving averages, suggesting short‑term pressure. The RSI sits around 40, indicating a neutral momentum, while the MACD remains bearish, and volume trends are decreasing, all pointing to a cautious near‑term outlook. Fundamentally, the company shows strong profitability (gross margin ~70%, ROE 22%) and a solid balance sheet with ample cash and minimal debt, but the market price exceeds the DCF fair value of CNY 11.43 and trades at a PE of 22 versus an industry average of 18, implying the stock is currently overvalued.
Despite the valuation gap, the dividend yield of 1.22% is supported by a modest payout ratio (~27%) and the company’s cash generation, making the dividend sustainable. Low beta (≈0.26) suggests limited market‑wide volatility, yet the 30‑day price volatility exceeds 110%, and the sector faces medium regulatory risk in China’s entertainment space, which should be factored into any investment horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish MACD
  • Decreasing volume and neutral RSI
  • Overvaluation relative to DCF and industry PE

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash generation and low debt
  • Sustainable dividend yield
  • Potential upside if valuation narrows

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust profitability and high ROE
  • Low systematic risk (beta) and solid balance sheet
  • Long‑term growth prospects in China’s entertainment market despite regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth247.50%
Profit Margin57.63%
P/E Ratio22.2
ROE22.01%
ROA13.54%
Debt/Equity0.55
P/B Ratio4.5
Op. Cash FlowCN¥2.8B
Free Cash FlowCN¥788.4M
Industry P/E17.9

Technical Analysis

TrendBullish
RSI40.0
SupportCN¥16.35
ResistanceCN¥29.88
MA 20CN¥19.84
MA 50CN¥18.59
MA 200CN¥18.39
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥11.43
Target PriceCN¥19.78
Upside/Downside18.63%
GradeOvervalued
TypeBlend
Dividend Yield1.22%

Risk Assessment

Beta0.26
Volatility114.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.